GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net…
Titomic – Driving Innovation and Securing the Future in FY2025
HUNTSVILLE, Ala., Aug. 27, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a global…
LOCKTON SURPASSES $4 BILLION IN FY2025 REVENUE, DRIVEN BY INDUSTRY-LEADING ORGANIC GROWTH AND RELENTLESS FOCUS ON CLIENTS
Global alignment and executive appointments fuel Lockton's fifth straight year of double-digit…
